Descrizione Clinica
Sobrepin aerosol 10fl 40mg 3ml Sobrefri
SOBREPIN AEROSOL 40 MG/3 ML SOLTING TO NEBULZATION
active ingredients
IT'S CALLED AEROSOL 40 mg/3 ml nebulizing solution Active ingredient: Sobrerolo 40 mg For the full list of excipients, see paragraph 6.1Excellent
Sodium chloride, water for injectable preparationsTherapeutic indications
Mucolitic, fluidizing in the acute and chronic affections of the respiratory system.Contraindications
Hypersensitivity to the active ingredient or any of the excipients listed in paragraph 6.1.Population
1 single-dose container for each aerosolized tubaric inhalation or catheterism for 1 or 2 applications per day.Conservation
Store in a dry place. This medicine does not require any special condition of conservation.Warnings
None.Interactions
Not known.Effects
Gastric disorders and nausea have been reported. Reporting of suspicious adverse reactions The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address www.agenziafarmaco.gov.it/content/come-segnalare-una-sospetta-reazione-avversaOverdosing
No overdose cases have been reported.Clinical data for pregnant and breast-feeding are not available. The administration of SOBREPIN AEROSOL during pregnancy and nursing with breast milk should be taken into account only if the expected benefit for the mother exceeds the risk for the fetus or child.
Source: Farmadati
